ACIP: 2023 Adult Immunization Schedule Updates
Several changes have been made to the adult immunization schedule 2023.
Several changes have been made to the adult immunization schedule 2023.
M-M-R II, Varivax, and ProQuad are supplied in single-dose vials as lyophilized vaccine for SC or IM injection after reconstitution.
The BLA is supported by data from a phase 3 trial which included approximately 7400 pregnant individuals.
Despite the availability of a highly effective shingles vaccine and almost universal risk among those born before 1980, Americans are not getting vaccinated.
The decision to discontinue the study was made based on an analysis from an independent data and safety monitoring board.
The approval was based on a re-analysis of data from on observational study of Tdap vaccine effectiveness in the US.
The bivalent vaccine contains the original strain of the SARS-CoV-2 virus and a strain from the BA.4 and BA.5 lineages of the Omicron variant.
Immune responses after Priorix administration were noninferior to those observed with M-M-R II.
The new liquid formulation of Rotarix does not require reconstitution or dilution before use.
The RSVpreF vaccine candidate consists of 2 prefusion F proteins selected to optimize protection against RSV A and B.